LGD 4033

LGD-4033 (15mg) is a specialized research reagent utilized primarily to investigate the biochemical pathways of selective androgen receptor modulation and the regulation of musculoskeletal protein synthesis. As a potent, non-steroidal Selective Androgen Receptor Modulator (SARM), it is a fundamental tool for exploring tissue-selective anabolic effects while minimizing androgenic activity in non-target tissues. Dragon Pharma provides LGD-4033 (Ligandrol) at a purity level of 99%+, specifically for use in in-vitro laboratory experiments and preclinical animal models.

Overview

In the realm of musculoskeletal biology and endocrine research, LGD-4033 has become a primary instrument for investigators exploring the androgen signaling axis. Known scientifically as Ligandrol, this compound offers high affinity and selectivity for the androgen receptor (AR), allowing for the study of muscle hypertrophy and bone mineralization without the systemic complications associated with traditional anabolic steroids. Dragon Pharma provides LGD-4033 15mg at a minimum purity of 99%, ensuring that researchers have access to a high-grade Research Compound capable of producing reproducible and accurate data in complex biological models.

As scientific inquiry into sarcopenia, cachexia, and age-related functional decline expands, the need for high-affinity SARMs like LGD-4033 has grown. This expanded profile examines the biochemical characteristics, structural integrity, and multifaceted research applications of LGD-4033 15mg.

Molecular Characteristics and Chemical Profile

The structural integrity of LGD-4033 is what allows it to bind to the androgen receptor with a high degree of tissue selectivity. By acting as a full agonist in skeletal muscle and bone, while acting as a partial agonist or antagonist in the prostate and sebaceous glands, it provides a unique framework for studying isolated anabolic signaling.

• Chemical Identity: LGD-4033 (4-((R)-2-((R)-2,2,2-trifluoro-1-hydroxyethyl)pyrrolidin-1-yl)-2-(trifluoromethyl)benzonitrile)
• Molecular Formula: $C_{14}H_{12}F_{6}N_{2}O$
• Molecular Weight: 338.25 g/mol
• Purity: >99% (HPLC and Mass Spectrometry verified)
• Form: Crystalline powder / Lyophilized powder
• Manufacturer: Dragon Pharma

Research Applications

The compound is utilized in various scientific investigative domains, including:

• Androgen Receptor Kinetics: Mapping the binding affinity ($K_{d}$) and transcriptional activation of the AR.
• Skeletal Muscle Hypertrophy: Investigating the modulation of myofibrillar protein synthesis and satellite cell activation.
• Bone Mineral Density: Studying the enhancement of osteoblastic activity and the suppression of osteoclast-mediated resorption.
• Tissue Selectivity: Assessing the anabolic-to-androgenic ratio compared to traditional testosterone models.
• Functional Recovery: Evaluating the impact of AR modulation on physical performance and recovery in wasting models.

Pathway and Mechanistic Context

The core value of LGD-4033 15mg in a laboratory setting is its ability to manipulate the Anabolic Signaling Pathway without causing the significant cross-reactivity seen with other steroidal ligands. In a natural physiological state, the androgen receptor is the primary driver of male secondary sexual characteristics and muscle mass maintenance.

The Selective Androgen Receptor Axis

Upon binding to the AR by LGD-4033, the receptor-ligand complex translocates to the nucleus. This initiates a global shift in cellular behavior, promoting the transcription of genes involved in structural protein production while avoiding the upregulation of genes associated with prostatic hypertrophy.

Key Mechanistic Shifts:

• Nitrogen Retention Potentiation: LGD-4033 facilitates the positive nitrogen balance necessary for muscle repair, providing a framework for studying regenerative biology.
• Myostatin Modulation: It influences the expression of myostatin and other growth-limiting factors, useful for research into advanced muscle-wasting diseases.
• Metabolic Adaptation: Researchers use LGD-4033 to observe how the activation of the AR pathway improves glucose utilization and lipid metabolism in muscle tissue.

Primary Research Applications

1. Sarcopenia and Muscle Atrophy Research

LGD-4033 is heavily utilized in studies involving age-related muscle loss. Statistics indicate that sarcopenia affects approximately 10% of adults over age 60, with prevalence increasing to over 50% in those over age 80. Research into health disparities shows that while prevalence is high across all groups, Non-Hispanic Black men often maintain higher baseline lean body mass but may experience steeper declines in functional strength compared to Caucasian counterparts in certain geriatric models. LGD-4033 provides a unique framework for investigating the restoration of lean mass in these varied models.

2. Cachexia and Oncology Support

Known in research circles for its "anti-wasting" potential, LGD-4033 is used to observe how tissues adapt to cancer-induced cachexia. Investigators study changes in lean body mass; in Phase I clinical trials, healthy subjects experienced a dose-dependent increase in lean body mass of up to 1.21 kg over just 21 days at a dose of only 1.0mg, demonstrating the high potency of the ligand.

3. Osteoporosis and Bone Resilience

In skeletal research, LGD-4033 is studied for its ability to improve bone mineral density (BMD). Research models focus on how SARM engagement can mitigate the bone loss associated with androgen deficiency and aging, particularly in post-menopausal or hypogonadal models.

Form and Analytical Testing

At Dragon Pharma, the commitment to scientific accuracy begins with a rigorous manufacturing process. LGD-4033 15mg is produced under strict laboratory conditions to ensure the compound remains stable and potent.

• Stability and Purity: The compound is optimized for long-term stability, removing impurities that could interfere with sensitive hormonal assays.
• Rigorous Analytical Verification: To guarantee a purity level of 99% or higher, every batch undergoes High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry (MS) to confirm that the chemical signature matches the verified LGD-4033 profile.